Skip to main content
Betta Pharmaceuticals Co.,Ltd logo

Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings

Ticker · 300558 ISIN · CNE100002DD9 LEI · 8368009YF4Y6NC7HVB09 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,657 across all filing types
Latest filing 2016-10-18 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300558

About Betta Pharmaceuticals Co.,Ltd

https://www.bettapharma.com

Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.

Recent filings

Filing Released Lang Actions
控股股东、实际控制人对招股意向书的确认意见
Regulatory Filings
2016-10-18 Chinese
国浩律师（杭州）事务所关于公司首次公开发行股票并在创业板上市之补充法律意见书（九）
Regulatory Filings Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding the initial public offering (IPO) and listing of a company (贝达药业股份有限公司) on the Growth Enterprise Market (创业板). It references multiple prior legal opinion letters and audit reports, discusses compliance with various laws and regulations, corporate governance, shareholder meetings, business operations, and legal qualifications for the IPO. The document is lengthy (15,000 characters) and contains substantive legal and regulatory analysis related to the IPO process, not just an announcement or summary. It is not a financial report, earnings release, or management discussion, but a legal opinion related to the IPO process. This type of document fits best under the category of Regulatory Filings (RNS) as it is a regulatory compliance document and legal opinion rather than a financial report or other specific filing type. There is no indication it is an audit report standalone, nor a proxy statement or voting results. It is not a report publication announcement since it contains the full legal opinion text. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2016-10-18 Chinese
2014年度股东大会会议决议
Regulatory Filings
2016-10-18 Chinese
非经常性损益专项审核说明（2013年1月1日至2016年6月30日）
Regulatory Filings
2016-10-18 Chinese
第二届董事会第三次会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the company's board of directors meeting, specifically the second board's third meeting. It records the approval of an investment project related to the company's initial public offering and listing on the Growth Enterprise Market. The content is about board decisions and approvals, not a full report or financial statement. It is not an announcement of voting results at a shareholder meeting, but a board meeting resolution. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board.
2016-10-18 Chinese
第一届董事会第四次会议决议
Regulatory Filings Classification · 95% confidence The document text is extremely short (399 characters) and contains only placeholders for images with no substantive text content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and is best classified as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings without clear classification.
2016-10-18 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.